Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Asia Pac J Ophthalmol (Phila) ; 11(5): 403-407, 2022 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-36094383

RÉSUMÉ

The coronavirus disease-2019 (COVID-19) pandemic introduced unique barriers to retinal care including limited access to imaging modalities, ophthalmic clinicians, and direct medical interventions. These unprecedented barriers were met with the robust implementation of digital advances to aid in monitoring and efficiency of retinal care while taking into the account of public safety. Many of these innovations have been successful in maintaining efficiency and patient satisfaction and are likely to stay to help preserve vision in the future. In this article we highlight these advances implemented during the pandemic including telescreening triage, virtual retinal imaging clinics, at-home optical coherence tomography, mobile phone self-monitoring, and virtual reality monitoring technology. We also discuss advancing innovations including Internet of Things and Blockchain technology that will be critical for further implementation and security of these digital advancements.


Sujet(s)
COVID-19 , COVID-19/épidémiologie , Contrôle des maladies transmissibles , Prévision , Humains , Pandémies/prévention et contrôle , Technologie
2.
Asia Pac J Ophthalmol (Phila) ; 9(5): 426-434, 2020.
Article de Anglais | MEDLINE | ID: mdl-32956188

RÉSUMÉ

PURPOSE: The aim of this consensus article was to provide comprehensive recommendations in the management of diabetic macular edema (DME) by reviewing recent clinical evidence. DESIGN: A questionnaire containing 47 questions was developed which encompassed clinical scenarios such as treatment response to anti-vascular endothelial growth factor and steroid, treatment side effects, as well as cost and compliance/reimbursement in the management of DME using a Dephi questionnaire as guide. METHODS: An expert panel of 12 retinal specialists from Singapore, Malaysia, Philippines, India and Vietnam responded to this questionnaire on two separate occasions. The first round responses were compiled, analyzed and discussed in a round table discussion where a consensus was sought through voting. Consensus was considered achieved, when 9 of the 12 panellists (75%) agreed on a recommendation. RESULTS: The DME patients were initially profiled based on their response to treatment, and the terms target response, adequate response, nonresponse, and inadequate response were defined. The panellists arrived at a consensus on various aspects of DME treatment such as need for classification of patients before treatment, first-line treatment options, appropriate time to switch between treatment modalities, and steroid-related side effects based on which recommendations were derived, and a treatment algorithm was developed. CONCLUSIONS: This consensus article provides comprehensive, evidence-based treatment guidelines in the management of DME in Asian population. In addition, it also provides recommendations on other aspects of DME management such as steroid treatment for stable glaucoma patients, management of intraocular pressure rise, and recommendations for cataract development.


Sujet(s)
Inhibiteurs de l'angiogenèse/administration et posologie , Consensus , Rétinopathie diabétique/traitement médicamenteux , Glucocorticoïdes/administration et posologie , Oedème maculaire/traitement médicamenteux , Acuité visuelle , Rétinopathie diabétique/complications , Rétinopathie diabétique/diagnostic , Études de suivi , Humains , Injections intravitréennes , Oedème maculaire/diagnostic , Oedème maculaire/étiologie , Études rétrospectives , Enquêtes et questionnaires , Résultat thérapeutique , Facteur de croissance endothéliale vasculaire de type A/antagonistes et inhibiteurs
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE